Table 3

Comparison of different Rx-risk scoring and modelling methods to predict 1-year mortality in the Department of Veterans’ Affairs (DVA) population and external validation using the Pharmaceutical Benefits Scheme (PBS) population

ModelsDVAPBS
AIC*Difference in AIC†C-statistic‡
(95% CI)
Relative IDI, P valuesAIC*Difference in AIC†C-statistic‡
(95% CI)
Relative IDI, P values
Base model (BM): age and sex80 538.50.738 (0.734 to 0.742)79 527.90.761 (0.756 to 0.766)
Rx-risk measures
  BM+unweighted Rx-risk79 420.11118.40.751 (0.747 to 0.754)14.0%, <0.000177 029.92498.00.796 (0.791 to 0.800)25.5%, <0.0001
  BM+DVA-weighted Rx-risk76 102.44436.10.786 (0.782 to 0.789)65.6%, <0.000173 143.86384.10.833 (0.829 to 0.837)92.0%, <0.0001
  BM+43 comorbidity indicators75 692.24846.30.791 (0.788 to 0.795)73.9%, <0.000171 689.17838.80.845 (0.842 to 0.849)114.8%, <0.0001
Crude measures
  BM+prescription count79 105.91432.60.755 (0.751 to 0.759)18.6%, <0.000176 762.82765.10.799 (0.795 to 0.804)31.4%, <0.0001
  BM+unique ATC§ medicine count78 374.52164.00.762 (0.758 to 0.766)29.4%, <0.000175 369.14158.80.814 (0.810 to 0.818)50.0%, <0.0001
  BM+unique PBS item code¶ medicine count78 210.22328.30.764 (0.760 to 0.768)32.1%, <0.000175 108.84419.10.816 (0.812 to 0.820)55.8%, <0.0001
  • *The model with the lowest AIC value is considered the best fit.

  • †AIC score compared with the AIC score of the base model. A model with a lower score of 10 (or more) is considered superior.

  • ‡Possible range 0–1, with 1 indicating perfect prediction and 0.5 indicating chance prediction. A c-statistic between 0.8 and 0.9 is generally considered as excellent, and between 0.7 and 0.8 acceptable.

  • §Anatomical Chemical Therapeutic (ATC) Classification System, count based on the number of unique ATC codes dispensed.

  • ¶PBS, count based on the number of unique PBS item codes dispensed.

  • AIC, Akaike information criterion model; IDI, integrated discrimination improvement.